Fans are expecting a sequel to Big Daddy, looking ahead to a comedy-filled adventure of Adam Sandler and Cole Sprouse. The hopeful fan base is excited to see Adam Sandler and Cole Sprouse in a ...
Hosted on MSN14d
Piper Sandler Downgrades Intra-Cellular Therapies (ITCI)Fintel reports that on January 14, 2025, Piper Sandler downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) from Overweight to Neutral. Analyst Price Forecast Suggests 16.75% ...
In the mid-2010s, the residents of Opelika, Alabama, became victims of a scam conducted by a self-proclaimed tech guru and former Google employee named Kyle Sandler. Attracting investors through his ...
On Tuesday, Piper Sandler analyst maintained an Overweight rating on Synopsys (NASDAQ:SNPS) stock with a price target of $655.00. Jeffries's statement highlighted the progress of Synopsys's ...
Piper Sandler analyst Biren Amin maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of $32.00. The company’s shares closed yesterday at ...
In a report released today, Ryan Todd from Piper Sandler maintained a Hold rating on Marathon Petroleum (MPC – Research Report), with a price target of $160.00. The company’s shares closed ...
Throughout his sprawling repertoire of cinematic work, Adam Sandler largely made his name off PG-13 movies, gathering a hefty following back in the ‘90s thanks to titles like Billy Madison ...
On Monday, Piper Sandler analyst Charles Neivert adjusted the investment firm's stance on Mosaic (NYSE: MOS), upgrading the stock from Underweight to Neutral with a price target (PT) set at $30.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback